Shanghai Pharma (601607)
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and in...
- Open
- 16.53
- High
- 16.60
- Low
- 16.42
- Prev. Close
- 16.55
- Volume
- 81.21K
- Turnover
- 134.13M
- Avg Price
- 16.52
- Bid/Ask Ratio
- --
- Amplitude
- 1.09%
- 52wk High
- 18.09
- Volume Ratio
- 0.37
- Turnover Ratio
- 0.29%
Shanghai Pharma Analyst Rating
View moreForecast & Rating
Sep 1, 2026Price forecast
¥20.8225.66%
Forecast & RatingBuy
8analysts
- Strong buy50.00%
- Buy12.50%
- Hold25.00%
- Sell0.00%
- Strong sell12.50%
News
- Tip Ranks · Sep 3 at 09:38 AM
Shanghai Pharmaceuticals Updates Interim Dividend and Tax Details for H Shareholders
- PUBT · Aug 24 at 12:56 AM
Shanghai Pharma, SIIC-controlled unit, steps up innovation push via national immunotherapy lab partnership
- PUBT · Aug 13 at 01:37 AM
Shanghai Industrial Investment president Zhang Qian visits Shanghai Pharmaceuticals Central Research Institute in Beijing for R&D review
- Tip Ranks · Jul 24 at 12:08 PM
Shanghai Pharmaceuticals Finalizes Participation in Shanghai Biomedical Phase II Fund
- Tip Ranks · Jul 17 at 12:39 PM
Shanghai Pharmaceuticals Joins RMB Biomedical Fund in Connected Transaction
- PUBT · Jul 15 at 01:01 AM
Shanghai Industrial chair visits Shanghai Pharma’s herbal medicine unit for reform review
